The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism
zur Mühlen, A., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945
Jenning, V., Thünemann, A. F., & Gohla, S. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00378-1 · Cited by 593
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties
Jenning, V., Schäfer-Korting, M., & Gohla, S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00223-0 · Cited by 545
Westesen, K., Bunjes, H., & Koch, M. H. J. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00046-1 · Cited by 536
Freitas, C., & Müller, R. H. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00074-5 · Cited by 483
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 476
Müller, R. H., Mehnert, W., Lucks, J. S., Schwarz, C., Mühlen, A. Z., Meyhers, H., de Freitas, C. F., & Rühl, D. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 455
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
Bunjes, H., Westesen, K., & Koch, M. H. J. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04286-5 · Cited by 425
Intestinal lymphatic drug transport: an update
Porter, C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00151-x · Cited by 337
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Yang, S., Zhu, J., Lu, Y., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324
Hu, F. Q., Yuan, H., Zhang, H. H., & Fang, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00081-9 · Cited by 284
Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
Cavalli, R. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04822-3 · Cited by 273
Peracchia, M. T., Gref, R., Minamitake, Y., Domb, A., Lotan, N., & Langer, R. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01597-0 · Cited by 266
CHEN, D.-B., YANG, T.-Z., LU, W.-L., & ZHANG, Q. (2001) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.49.1444 · Cited by 243
Niosomes as carriers for tretinoin. I. Preparation and properties
Manconi, M., Sinico, C., Valenti, D., Loy, G., & Fadda, A. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00971-1 · Cited by 211
Westesen, K., Siekmann, B., & Koch, M. H. J. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90177-h · Cited by 206
Na, K., Park, K.-H., Kim, S. W., & Bae, Y. H. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00256-x · Cited by 177
Olbrich, C., Kayser, O., & Müller, R. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00035-2 · Cited by 173
Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix?
Westesen, K., & Bunjes, H. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00347-8 · Cited by 149
Piemi, M. P. Y., Korner, D., Benita, S., & Marty, J.-P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00156-4 · Cited by 149
Preparation and characterization of solid lipid nanospheres containing paclitaxel
Cavalli, R., Caputo, O., & Gasco, M. R. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00081-6 · Cited by 149
Production of solid lipid nanoparticles (SLN): scaling up feasibilities
Dingler, A., & Gohla, S. (2002) · Journal of Microencapsulation · doi:10.1080/02652040010018056 · Cited by 143
Zara, G. P., Bargoni, A., Cavalli, R., Fundaro', A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10129 · Cited by 143
Jann, M. W. (1991) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1991.tb02628.x · Cited by 132
Cavalli, R. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00066-6 · Cited by 125
Cited by
Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems
Mishra, V., Bansal, K. K., Verma, A., Yadav, N., Thakur, S., Sudhakar, K., & Rosenholm, J. M. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040191 · Cited by 669
Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles
Li, H., Zhao, X., Ma, Y., Zhai, G., Li, L., & Lou, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.002 · Cited by 666
Potential of solid lipid nanoparticles in brain targeting.
Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615
Gordillo-Galeano, A., & Mora-Huertas, C. E. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.10.017 · Cited by 569
Nanoparticles: Emerging carriers for drug delivery
Mudshinge, S. R., Deore, A. B., Patil, S., & Bhalgat, C. M. (2011) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2011.04.001 · Cited by 543
Metadata
- Authors
- Venkateswarlu, V., & Manjunath, K.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 95
- Issue
- 3
- Pages
- 627-638
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1964026121
- Cited by
- 558
- References
- 27
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.